We highlight the importance of recognizing scarring alopecia as a complication of DEB, with discernment for concomitant inflammatory etiologies that may co-occur, especially in a patient with a COL7A1 mutation. This evidence concerns the gene COL7A1 and Dystrophic epidermolysis bullosa.